FLML News Alert Flamel Technologies S.A. (FLML) 14.15 02/13/2015

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 12:49 AM

Flamel Technologies S.A. (FLML) 14.15 $FLML

3 Biotech Stocks to Buy in February
Motley Fool Staff - Motley Fool - Mon Feb 02, 9:01AM CST
When it comes to figuring out the best stocks to buy in any given month or year, crystal balls can be hazy, but our top Motley Fool contributors have scoured SEC filings, read industry trade journals, and crunched numbers to uncover three biotech...
FLML: 14.15 (+0.15), BMRN: 100.76 (+1.98), RNA: 18.65 (unch), CELG: 115.88 (+0.16)

Flamel Technologies Responds To Competition With Significant Bloxiverz Price Increase
Ronny Hyman - at Seeking Alpha - Fri Jan 23, 3:25PM CST

FLML: 14.15 (+0.15)

Flamel Technologies (FLML) in Focus: Stock Gains 15.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 19, 8:25AM CST
Flamel Technologies (FLML) was a big mover last session, with shares rising over 15% on the day.
BCRX: 10.06 (-0.09), FLML: 14.15 (+0.15)

Nasdaq stocks posting largest percentage increases
AP - Fri Jan 16, 5:20PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
FLML: 14.15 (+0.15), EOPN: 8.55 (-0.01), DEPO: 18.38 (+0.20), NYNY: 6.33 (+0.06), CRRC: 22.96 (+0.22), AREX: 8.15 (+0.27)

After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Jan 16, 4:36PM CST

SCCO: 30.43 (+0.30), FLML: 14.15 (+0.15), GDP: 3.58 (+0.29), PBF: 30.18 (+0.27), DGAZ: 7.10 (-0.49), IAG: 2.23 (-0.08), REXX: 5.08 (+0.13), SFUN: 6.74 (-0.01), ALKS: 71.40 (-1.89), XOMA: 3.41 (-0.01)

Flamel Technologies reports rise in Bloxiverz price
M2 - Fri Jan 16, 7:36AM CST
Drug delivery company Flamel Technologies (NASDAQ:FLML) declared on Thursday that the Wholesale Acquisition Cost (WAC) for Bloxiverz has been raised to USD98.75 per vial for both the 0.5 and 1.0 mg/mL strengths.
FLML: 14.15 (+0.15)

Nasdaq stocks posting largest volume increases
AP - Thu Jan 15, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
CRME: 9.76 (-0.14), SMSI: 1.60 (+0.07), DNBF: 22.59 (-0.41), PODD: 32.00 (-0.07), FLML: 14.15 (+0.15), QADB: 17.59 (+0.05), QADA: 20.36 (+0.14), WBKC: 23.75 (+0.03), COM.TO: 12.06 (-0.12), CMSB: 13.19 (+0.13), DWCH: 6.26 (-0.18)

Flamel Technologies Announces Price Change for Bloxiverz
Marketwired - Thu Jan 15, 10:20AM CST
Flamel Technologies (NASDAQ: FLML) today announced that the Wholesale Acquisition Cost (WAC) for Bloxiverz has been increased to $98.75 per vial for both the 0.5 and 1.0 mg/mL strengths. Bloxiverz (neostigmine methylsulfate), which Flamel launched in July 2013, is used intravenously in the operating room for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery.
FLML: 14.15 (+0.15), GSK: 47.94 (+1.99)

Flamel Technologies (FLML) Is Today's Dead Cat Bounce Stock
at The Street - Thu Jan 15, 8:45AM CST
Trade-Ideas LLC identified Flamel Technologies (FLML) as a "dead cat bounce" (down big yesterday but up big today) candidate
FLML: 14.15 (+0.15)

Market Maker Surveillance Report. FLML, MDLY, DGAZ, DWTI, ANFI, MOLG, Losing Stocks With Lowest Price Friction For Wednesday, January 14th 2015
M2 - Thu Jan 15, 1:27AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 5246 companies with "abnormal" market making, 2382 companies with positive Friction Factors and 3871 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Wednesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Flamel Technologies SA (NASDAQ:FLML), MEDLEY CREDIT (NYSE:MDLY), (NYSE

GAZ), (NYSE

WTI), (NYSE:ANFI), (NASDAQ:MOLG). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
MOLG: 2.46 (+0.03), MDLY: 10.44 (-0.10), FLML: 14.15 (+0.15), DGAZ: 7.10 (-0.49), DWTI: 95.90 (-7.40), ANFI: 8.84 (-0.42)

More bad news for Flamel
Seeking Alpha - at Seeking Alpha - Wed Jan 14, 12:46PM CST

FLML: 14.15 (+0.15)

Flamel Technologies Update to Shareholders on Neostigmine Methylsulfate
Marketwired - Wed Jan 14, 12:15PM CST
Flamel Technologies (NASDAQ: FLML) today learned the U.S. Food and Drug Administration (FDA) has approved Fresenius Kabi's New Drug Application (NDA) for neostigmine methylsulfate, a drug which Flamel currently markets as Bloxiverz.
FLML: 14.15 (+0.15)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Jan 14, 11:43AM CST

BEBE: 3.90 (+0.01), MDLY: 10.44 (-0.10), ZIOP: 9.64 (-0.35), GME: 37.35 (+0.10), FCX: 20.29 (+0.82), BGC: 14.40 (+0.51), HBM: 8.34 (+0.21), XON: 39.30 (+1.05), BBEP: 7.85 (+0.32), PES: 5.74 (+0.54), AAMC: 173.53 (-8.22), DWCH: 6.26 (-0.18), SMSI: 1.60 (+0.07), ETRM: 1.21 (+0.06), FLML: 14.15 (+0.15), EEI: 10.28 (-0.11), FCSC: 4.75 (+0.50), QURE: 19.83 (-0.18), ERII: 3.36 (+0.01), KONE: 4.20 (+0.03)

Flamel sinks on Jazz Pharma patent ruling
Seeking Alpha - at Seeking Alpha - Wed Jan 14, 10:51AM CST

FLML: 14.15 (+0.15), B: 37.40 (+0.44), JAZZ: 169.69 (+6.89)

Uptrend Call Working As Flamel Technologies Stock Rises 34.8% (FLML)
Comtex SmarTrend(R) - Thu Jan 08, 9:08AM CST
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on November 25th, 2014 at $14.23. In approximately 1 month, Flamel Technologies has returned 34.75% as of today's recent price of $19.17.
FLML: 14.15 (+0.15)

Flamel Technologies Up 20.4% Since SmarTrend Uptrend Call (FLML)
Comtex SmarTrend(R) - Wed Dec 31, 5:01PM CST
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on November 25th, 2014 at $14.23. In approximately 1 month, Flamel Technologies has returned 20.38% as of today's recent price of $17.13.
FLML: 14.15 (+0.15)

Flamel Technologies Has Returned 21.4% Since SmarTrend Recommendation (FLML)
Comtex SmarTrend(R) - Wed Dec 24, 11:03AM CST
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on November 25th, 2014 at $14.23. In approximately 4 weeks, Flamel Technologies has returned 21.36% as of today's recent price of $17.27.
FLML: 14.15 (+0.15)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Venue Two Eleven: Historic Charm Meets Modern Events

Welcome To Venue Two Eleven: Where History Meets Modernity Alright, folks. Let’s talk about Venue Two Eleven—a new joint in town that’s blending the old with the new in a way that’s got me raising an eyebrow and maybe even sipping my coffee a little slower. Nestled in the Museum of the Oregon Territory, this place is pulling double duty as both a window to the...

Workday Hits High Note in 2026 Gartner Magic Quadrant

Workday Secures Leadership Position In a wild ride that's left investors with whiplash in recent years, Workday (NASDAQ: WDAY) has firmly planted its flag at the top tier of the 2026 Gartner® Magic Quadrant™ for Cloud ERP Finance. This announcement out of Pleasanton, California, resonates like a victory bell for the company's finance management solutions—a mix of AI,...

Coastal Financial Faces Lawsuit Over Fraud Allegations

Coastal Financial Corporation, riding high on NASDAQ as CCB, now finds itself in the middle of a storm. Schall, Brown & Schwartz LLP, a firm known for its shareholder rights litigation, has thrown the gauntlet with a class action lawsuit against Coastal for suspected securities violations. We're talking about potential fibs under Section 10(b) and 20(a) of the Securities...

Understanding Truck Accident Settlements in Memphis

Delving into Truck Accident Settlement Timelines Out there in Memphis, timing a truck accident settlement isn't exactly like clockwork work. When it comes to getting your compensation, the timeline varies as widely as a duck hunting trip—sometimes you come home with a basketful, sometimes it’s empty. It might be a quick couple of months or drag on past a year, and...

LINC Lawsuit: Boardroom Stumbles Spark Investor Action

Class Action Kickoff: Lincoln's Educational Curveball No one fancies home runs when the ball’s out of sight, and that’s probably how some investors in Lincoln Educational Services Corporation (NASDAQ: LINC) are feeling right now. A group of shareholders has pulled back the curtain on what they believe are more than just administrative hiccups—allegations of...

Navigating Braces vs. Invisalign: Key Considerations

Choice Between Braces and Invisalign Isn't Straightforward When you're pondering over whether to go with braces or Invisalign, it ain't just a choice you make lightly over coffee. It's a nuanced decision that hinges on a multitude of factors as highlighted by orthodontic experts Dr. Erik Higginbottom and Dr. Kyle Higginbottom from Easton, MD, featured in HelloNation's...

Noé Hinojosa Jr. Honored for Leadership in Business

From Bonds to Ballgames: Hinojosa's Impact Listen up, because this one’s more than just another accolade on a shelf. Noé Hinojosa Jr., a big gun over at TRB Securities, is getting the 2026 Hispanic Business Salute Award, and it's a doozy. Awarded by all the big wigs—UPS, NBC 5, Telemundo 39, and the Dallas Cowboys—this isn't a small pat on the back. It's a full-on...

Netcapital Faces Securities Fraud Claims: Key Investor Notes

Netcapital Under Fire: The Suit Unfolds You ever see a stock go through such highs and lows that you wish you had popcorn on standby? Well, that's where Netcapital Inc. (NASDAQ: NCPL) is sitting right now, in the midst of a class action lawsuit that's got investors' heads spinning. The accusations are serious: false and misleading statements about revenues that seem to...

Encompass Health: Leader in Rehabilitation Again in 2026

Pinnacle of Rehab: Encompass Health's Notable Streak You know, in a world where healthcare accolades fly around like confetti, Encompass Health Corp's persistence in being named America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek for the seventh straight year is something to chew on. The fact that a record 78 of its hospitals dotted across 32 states...

AI-Designed Antivirals: A Brave New World

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...